Norepinephrine as a Potential Aggravator of Symptomatic Cerebral Vasospasm: Two Cases and Argument for Milrinone Therapy
Background. During hypertensive therapy for post-subarachnoid hemorrhage (SAH) symptomatic vasospasm, norepinephrine is commonly used to reach target blood pressures. Concerns over aggravation of vasospasm with norepinephrine exist. Objective. To describe norepinephrine temporally related deterior...
Main Authors: | F. A. Zeiler, J. Silvaggio, A. M. Kaufmann, L. M. Gillman, M. West |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2014/630970 |
Similar Items
-
Early Angiographic Resolution of Cerebral Vasospasm with High Dose Intravenous Milrinone Therapy
by: F. A. Zeiler, et al.
Published: (2015-01-01) -
Effects of Milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping
by: Mohamed A. Ghanem, et al.
Published: (2014-01-01) -
Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study
by: Rabie Soliman, et al.
Published: (2019-01-01) -
Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage.
by: Maimaitili Mijiti, et al.
Published: (2016-01-01) -
Correction: Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage.
by: PLOS ONE Staff
Published: (2017-01-01)